The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
PAAB Forum Quarterly Review - Q1/2024
-
Happy Wednesday @Manufacturer @Agency
The PAAB Forum Quarterly Review giving a run down of the activities at PAAB over the last quarter, has been posted.
Please pop comments and questions in the chat below.
Have a great week.
